2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新)

2019-09-05 欧洲小儿肺血管病网络 J Heart Lung Transplant. 2019 Sep;38(9):879-901.

2019年9月,欧洲小儿肺血管病网络(EPPVDN)更新发布了儿童肺动脉高压的诊断和治疗共识,内容涉及诊断,监测、遗传/生物学标志物,心导管检查,超声心动图,心脏MRI/CT以及肺动脉高压的治疗。

中文标题:

2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新)

英文标题:

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.

发布日期:

2019-09-05

简要介绍:

2019年9月,欧洲小儿肺血管病网络(EPPVDN)更新发布了儿童肺动脉高压的诊断和治疗共识,内容涉及诊断,监测、遗传/生物学标志物,心导管检查,超声心动图,心脏MRI/CT以及肺动脉高压的治疗。

 

拓展指南:肺动脉高压相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新))] GetToolGuiderByIdResponse(projectId=1, id=20f711c001e93904, title=2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新), enTitle=2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT., guiderFrom=J Heart Lung Transplant. 2019 Sep;38(9):879-901., authorId=null, author=, summary=2019年9月,欧洲小儿肺血管病网络(EPPVDN)更新发布了儿童肺动脉高压的诊断和治疗共识,内容涉及诊断,监测、遗传/生物学标志物,心导管检查,超声心动图,心脏MRI/CT以及肺动脉高压的治疗。 , cover=, journalId=null, articlesId=null, associationId=1827, associationName=欧洲小儿肺血管病网络, associationIntro= , copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年9月,欧洲小儿肺血管病网络(EPPVDN)更新发布了儿童肺动脉高压的诊断和治疗共识,内容涉及诊断,监测、遗传/生物学标志物,心导管检查,超声心动图,心脏MRI/CT以及肺动脉高压的治疗。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>肺动脉高压</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2018 TSOC指南:肺动脉高压的诊断和治疗(更新版)" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=889751c001e257b1">2018 TSOC指南:肺动脉高压的诊断和治疗(更新版)</A> <LI><A title="2018 CHEST指南:成人肺动脉高压的治疗" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=2e7961c001693eb8">2018 CHEST指南:成人肺动脉高压的治疗</A> <LI><A title=中国肺动脉高压诊断和治疗指南2018 target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=286cf1c0016918b4">中国肺动脉高压诊断和治疗指南2018</A> <LI><A title="2018 科隆共识会议建议:成人先天性心脏病患者肺动脉高压" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=a57251c0016a2e60">2018 科隆共识会议建议:成人先天性心脏病患者肺动脉高压</A> <LI><A title="2018 科隆共识会议建议:肺动脉高压的定义,临床分类和初始诊断" target=_blank href="https://www.medsci.cn/guideline/show_article.do?id=45b601c0016a1919">2018 科隆共识会议建议:肺动脉高压的定义,临床分类和初始诊断</A> 更多信息请点击:<A target=_blank href="https://www.medsci.cn/guideline/list.do?q=%E8%82%BA%E5%8A%A8%E8%84%89%E9%AB%98%E5%8E%8B">有关肺动脉高压更多指南</A></LI></UL>, tagList=[TagDto(tagId=28782, tagName=儿童肺动脉高压)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5997, appHits=414, showAppHits=12, pcHits=3689, showPcHits=3315, likes=53, shares=21, comments=5, approvalStatus=1, publishedTime=Sun Sep 22 22:22:07 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:22:07 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:12:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新))])
2019 EPPVDN共识声明:儿童肺动脉高压的诊断和治疗(更新)
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998145, encodeId=379b998145cb, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/2f8f518464344326a3aa7c9a72f8bb28/bf35ef205ef5417bbf8147c6904a0c20.jpg, createdBy=73cb5314814, createdName=1489609am79暂无昵称, createdTime=Sat Jul 10 09:06:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975574, encodeId=a2e29e557429, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=595d4712903, createdName=404009140, createdTime=Mon Jun 21 21:19:37 CST 2021, time=2021-06-21, status=1, ipAttribution=)]
    2021-07-10 1489609am79暂无昵称

    厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998145, encodeId=379b998145cb, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/2f8f518464344326a3aa7c9a72f8bb28/bf35ef205ef5417bbf8147c6904a0c20.jpg, createdBy=73cb5314814, createdName=1489609am79暂无昵称, createdTime=Sat Jul 10 09:06:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975574, encodeId=a2e29e557429, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=595d4712903, createdName=404009140, createdTime=Mon Jun 21 21:19:37 CST 2021, time=2021-06-21, status=1, ipAttribution=)]
    2021-06-21 404009140

    厉害

    0